Biogen (BIIB) Return on Invested Capital Growth (3y) (2016 - 2025)
Biogen (BIIB) Return on Invested Capital Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.00 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.00 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.00 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -95.00 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -1.00 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -1.00 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 1.00 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 13.00 |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.00 |
| Jun 30, 2025 | -2.00 |
| Mar 31, 2025 | -3.00 |
| Sep 30, 2020 | 1.00 |
| Jun 30, 2020 | 0.00 |
| Mar 31, 2020 | -8.00 |
| Dec 31, 2018 | 791.00 |
| Sep 30, 2018 | -160.00 |
| Jun 30, 2018 | -270.00 |
| Mar 31, 2018 | -251.00 |
| Dec 31, 2017 | -219.00 |
| Sep 30, 2017 | -183.00 |
| Jun 30, 2017 | -155.00 |
| Mar 31, 2017 | -153.00 |
| Dec 31, 2016 | 191.00 |
| Sep 30, 2016 | 146.00 |
| Jun 30, 2016 | 115.00 |
| Mar 31, 2016 | 116.00 |